Sutro Biopharma Inc Sustainability Reports
Sutro Biopharma, Inc. discovers, develops, and manufactures next-generation cancer and autoimmune therapeutics using its proprietary cell-free protein synthesis platform.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
LEI: 5493005U6P15VD25P851
8 reports from 2019 to 2025